FDP
PTCT icon

Financiere des Professionnels’s PTC Therapeutics PTCT Stock Holding History

Financiere des Professionnels’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.1M Buy
13,502
+6,274
+87% +$453K 0.06% 190
2026
Q1 		$492K Buy
7,228
+1,407
+24% +$99.6K 0.03% 239
2025
Q4 		$442K Hold
5,821
– – 0.03% 229
2025
Q3 		$357K Hold
5,821
– – 0.02% 260
2025
Q2 		$284K Buy
+5,821
New +$276K 0.02% 254

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Financiere des Professionnels's PTCT Position: Q2 2026 in Review

Financiere des Professionnels increased its PTC Therapeutics (PTCT) stake by 87% in Q2 2026, buying an estimated $453K and bringing the position to 13,502 shares worth $1.1M. The position accounts for 0.06% of the portfolio, ranked #190.

Financiere des Professionnels first reported a position in PTCT in Q2 2025 and has held it in 5 quarters since. 383 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Financiere des Professionnels held 13,502 shares of PTC Therapeutics worth $1.1M as of Q2 2026.
  • Financiere des Professionnels bought 6,274 PTC Therapeutics shares in Q2 2026, an estimated $453K.
  • PTC Therapeutics made up 0.06% of Financiere des Professionnels's portfolio in Q2 2026, its #190 holding.
  • Financiere des Professionnels first reported a position in PTC Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 383 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Financiere des Professionnels's 13F filing for Q2 2026, filed 5 Aug 2026.